ED Treatment of Suicidal Patients With Ketamine Infusion

Withdrawn before enrolling · Phase 2

Conditions studied: Suicide, Suicidal Ideation

In brief

This study aims to determine if a single intravenous (IV) dose of ketamine given in the emergency department (ED) can provide a long term reduction in suicidal ideation, lower time to ED discharge, and increase discharge to home or voluntary treatment facilities all while being safe.

Key facts

Study ID

NCT03502551

Run by

University of California, Davis

People needed

0

Starts

2019-04-01

Expected to finish

2019-06-30

Last updated by the study team

2019-05-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 18 years
• Chief complaint of suicidal thoughts with a MADRS-SI score > 3
• Major depressive episode with MADRS > 19 (moderate to severe)

You may not qualify if…

• Pregnancy
• Psychosis
• Acute intoxication with alcohol or illicit drugs
• Acute withdrawal from alcohol or illicit drugs
• Adults otherwise unable to consent
• Concurrent, active medical illness requiring medical hospitalization
• Inability to follow-up including no permanent address or valid telephone number
• Patients unable to attend outpatient follow-up (no medical insurance, refusal to follow-up, no established care provider)
• Specific contraindication to the use of ketamine (concern for increased intracranial or intraocular pressure, known allergy to ketamine)
• Greater than 12 hours from time of ED presentation
• Prisoners

Where it is running

• University of California Davis Medical Center — Sacramento, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.